Literature DB >> 31711158

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.

Joana Torres1, Stefanos Bonovas2,3, Glen Doherty4, Torsten Kucharzik5, Javier P Gisbert6, Tim Raine7, Michel Adamina8,9, Alessandro Armuzzi10, Oliver Bachmann11, Palle Bager12, Livia Biancone13, Bernd Bokemeyer14, Peter Bossuyt15, Johan Burisch16, Paul Collins17, Alaa El-Hussuna18, Pierre Ellul19, Cornelia Frei-Lanter20, Federica Furfaro3, Christian Gingert21,22, Paolo Gionchetti23, Fernando Gomollon24, Marien González-Lorenzo2,3, Hannah Gordon25, Tibor Hlavaty26, Pascal Juillerat27, Konstantinos Katsanos28, Uri Kopylov29, Eduards Krustins30, Theodore Lytras31, Christian Maaser32, Fernando Magro33, John Kenneth Marshall34, Pär Myrelid35, Gianluca Pellino36, Isadora Rosa37, Joao Sabino38, Edoardo Savarino39, Antonino Spinelli40, Laurents Stassen41, Mathieu Uzzan42, Stephan Vavricka43, Bram Verstockt44,45, Janindra Warusavitarne46, Oded Zmora47, Gionata Fiorino2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31711158     DOI: 10.1093/ecco-jcc/jjz180

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  148 in total

1.  The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study.

Authors:  Johan Burisch; Daniel Bergemalm; Jonas Halfvarson; Viktor Domislovic; Zeljko Krznaric; Adrian Goldis; Jens F Dahlerup; Pia Oksanen; Pekka Collin; Luisa de Castro; Vicent Hernandez; Svetlana Turcan; Elena Belousova; Renata D'Incà; Alessandro Sartini; Daniela Valpiani; Martina Giannotta; Ravi Misra; Naila Arebi; Dana Duricova; Martin Bortlik; Kelly Gatt; Pierre Ellul; Natalia Pedersen; Jens Kjeldsen; Karina W Andersen; Vibeke Andersen; Konstantinos H Katsanos; Dimitrios K Christodoulou; Shaji Sebastian; Luisa Barros; Fernando Magro; Jóngerð Mm Midjord; Kári R Nielsen; Riina Salupere; Hendrika Al Kievit; Gediminas Kiudelis; Juozas Kupčinskas; Mathurin Fumery; Corinne Gower-Rousseau; Ioannis P Kaimakliotis; Doron Schwartz; Selwyn Odes; Laszlo Lakatos; Peter L Lakatos; Ebbe Langholz; Pia Munkholm
Journal:  United European Gastroenterol J       Date:  2020-07-26       Impact factor: 4.623

Review 2.  Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.

Authors:  G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-01-25       Impact factor: 3.781

3.  The "star sign" in Crohn's disease.

Authors:  Dario Giambelluca; Francesca Interlicchia; Giuseppe Capodieci
Journal:  Abdom Radiol (NY)       Date:  2021-01-19

Review 4.  Location is important: differentiation between ileal and colonic Crohn's disease.

Authors:  Raja Atreya; Britta Siegmund
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-12       Impact factor: 46.802

Review 5.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Authors:  G Pellino; D S Keller; G M Sampietro; I Angriman; M Carvello; V Celentano; F Colombo; F Di Candido; S Laureti; G Luglio; G Poggioli; M Rottoli; S Scaringi; G Sciaudone; G Sica; L Sofo; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-14       Impact factor: 3.781

Review 6.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis.

Authors:  G Pellino; D S Keller; G M Sampietro; M Carvello; V Celentano; C Coco; F Colombo; A Geccherle; G Luglio; M Rottoli; M Scarpa; G Sciaudone; G Sica; L Sofo; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-02       Impact factor: 3.781

7.  Clinical Considerations Regarding the Use of Thiopurines in Older Patients with Inflammatory Bowel Disease.

Authors:  Margalida Calafat; Míriam Mañosa; Fiorella Cañete; Eugeni Domènech
Journal:  Drugs Aging       Date:  2021-01-13       Impact factor: 3.923

8.  Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review.

Authors:  Calen A Steiner; Jeffrey A Berinstein; Jeremy Louissaint; Peter D R Higgins; Jason R Spence; Carol Shannon; Cathy Lu; Ryan W Stidham; Joel G Fletcher; David H Bruining; Brian G Feagan; Vipul Jairath; Mark E Baker; Dominik Bettenworth; Florian Rieder
Journal:  Clin Gastroenterol Hepatol       Date:  2021-06-02       Impact factor: 11.382

Review 9.  Vedolizumab in Inflammatory Bowel Disease: West versus East.

Authors:  Prasanta Debnath; Pravin M Rathi
Journal:  Inflamm Intest Dis       Date:  2021-01-27

Review 10.  Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease.

Authors:  Akira Andoh; Masahiro Kawahara; Takayuki Imai; Goichi Tatsumi; Osamu Inatomi; Yoichi Kakuta
Journal:  J Gastroenterol       Date:  2021-07-21       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.